I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| mast cell | 8 studies | 25% ± 7% | |
| epithelial cell | 6 studies | 23% ± 7% | |
| GABAergic neuron | 6 studies | 44% ± 20% | |
| endothelial cell | 5 studies | 23% ± 3% | |
| glutamatergic neuron | 5 studies | 50% ± 24% | |
| ciliated cell | 4 studies | 22% ± 8% | |
| oligodendrocyte precursor cell | 4 studies | 24% ± 8% | |
| alveolar macrophage | 4 studies | 26% ± 10% | |
| GABAergic interneuron | 3 studies | 24% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 24% ± 8% | |
| CD4-positive, alpha-beta T cell | 3 studies | 18% ± 4% | |
| Mueller cell | 3 studies | 27% ± 5% | |
| club cell | 3 studies | 19% ± 1% | |
| natural killer cell | 3 studies | 20% ± 2% | |
| type II pneumocyte | 3 studies | 19% ± 2% | |
| lymphocyte | 3 studies | 29% ± 8% | |
| astrocyte | 3 studies | 36% ± 11% | |
| interneuron | 3 studies | 50% ± 10% |
